!!RICH_SEQUENCE 1.0
..
{
name 1tlk_
descrip 
creator 
type    PROTEIN
group 1
feature 2625 2631 0 square solid STRUCT
  FT   STRUCT        8     14  STRAND
feature 2636 2639 0 square solid STRUCT
  FT   STRUCT       19     22  STRAND
feature 2644 2653 0 square solid STRUCT
  FT   STRUCT       27     36  STRAND
feature 2661 2666 0 square solid STRUCT
  FT   STRUCT       40     45  STRAND
feature 2673 2674 0 square solid STRUCT
  FT   STRUCT       48     49  STRAND
feature 2696 2700 0 square solid STRUCT
  FT   STRUCT       56     60  STRAND
feature 2709 2714 0 square solid STRUCT
  FT   STRUCT       65     70  STRAND
feature 2719 2721 3 square solid STRUCT
  FT   STRUCT       75     77  HELIX
feature 2723 2731 0 square solid STRUCT
  FT   STRUCT       79     87  STRAND
feature 2734 2753 0 square solid STRUCT
  FT   STRUCT       90    101  STRAND
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .....................................VAEEKPHVKPYFTKTILDMDVVE
  GSAARFDCKVEGY....PDPEVMWFKD....DNPVKE...............SRHFQIDY
  DEE....GNCSLTISEVCGDDDAKYTCKAVNSLG........EATCTAELLVETM.....
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name CNEX_MOUSE
descrip 
creator 
type    PROTEIN
group 1
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .............................................MEKFLFYLFLIGIAV
  RAQICPKRCVCQILSPNLATLCAKKGLLFVPPNIDRRTVELRLADNFVTNIKRKDFANMT
  SLVDLTLSRNTISFITPHAFADLRNLRALHLNSNRLTKITNDMFSGLSNLHHLILNNNQL
  TLISSTAFDDVFALEELDLSYNNLETIPWDAVEKMVSLHTLSLDHNMIDNIPKGTFSHLH
  KMTRLDVTSNKLQKLPPDPLFQRAQVLATSG.............................
  ............................................................
  ............................................................
  ............................................................
  ...........................................IISPSTFALSFGGNPLH
  C...NCELLWLRRLSREDDLETCASPALLTGRYFWSIPEEEFLCEPPLITRHTHEMRVLE
  GQRATLRCKARGD....PEPAIHWISP....EGKLISNA.............TRSLVYDN
  .........GTLDILITTVKDTGAFTCIASNPAG........EATQTVDLHIIKLPHLLN
  STNHIHEPDPGSSDISTSTKSGSNASSSNGDTKMSQDKIVVAEATSSTALLKFNFQRNIP
  GIRMFQIQYNGTYDDTLVYRMIPPTSKTFLVNNLASGTMYDLCVLAIYDDGITSLTATRV
  VGCIQFTTEQDYVRCHFMQSQFLGGTMIIIIGGIIVASVLVFIIILMIRYKVCNNNGQHK
  VTKVSNVYSQTNGAQMQGCSVTLPQSMSKQAMGHEENAQCCKVASDNAIQSSETCSSQDS
  STTTSALPPTWTSSAPVSQKQKRKTGTKPSAEPQSEAVTNVESQNTNRNNSTALQLASCP
  PDSVTEGPTSQRAHTKPNALLTNVDQNVQETQRLESI.......................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name TRIO_HUMAN
descrip Triple functional domain protein (PTPRF interacting protein)
creator Homo sapiens (Human).Eukaryota;
type    PROTEIN
group 1
feature 6 151 5 square solid DOMAIN
  FT   DOMAIN        6    151  CRAL-TRIO.
feature 1233 1408 5 square solid DOMAIN
  FT   DOMAIN     1233   1408  DH 1.
feature 1421 1532 5 square solid DOMAIN
  FT   DOMAIN     1421   1532  PH 1.
feature 1597 1653 5 square solid DOMAIN
  FT   DOMAIN     1597   1653  SH3.
feature 1910 2086 5 square solid DOMAIN
  FT   DOMAIN     1910   2086  DH 2.
feature 2098 2212 5 square solid DOMAIN
  FT   DOMAIN     2098   2212  PH 2.
feature 2626 2751 5 square solid DOMAIN
  FT   DOMAIN     2626   2716  Ig-like C2-type.
feature 2772 3028 5 square solid DOMAIN
  FT   DOMAIN     2737   2993  Protein kinase.
feature 656 659 5 square solid DOMAIN
  FT   DOMAIN      656    659  Poly-Gln.
feature 1786 1791 5 square solid DOMAIN
  FT   DOMAIN     1786   1791  Poly-Ser.
feature 2233 2253 5 square solid DOMAIN
  FT   DOMAIN     2233   2253  Poly-Gly.
feature 2486 2492 5 square solid DOMAIN
  FT   DOMAIN     2486   2492  Poly-Ser.
feature 1421 1532 0 square solid PFAM-A
  FT   PFAM-A     1421   1532  PF00169 PH
feature 2099 2212 0 square solid PFAM-A
  FT   PFAM-A     2099   2212  PF00169 PH
feature 1237 1407 1 square solid PFAM-A
  FT   PFAM-A     1237   1407  PF00621 RhoGEF
feature 1914 2085 1 square solid PFAM-A
  FT   PFAM-A     1914   2085  PF00621 RhoGEF
feature 1600 1640 2 square solid PFAM-A
  FT   PFAM-A     1600   1640  PF00018 SH3
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A     2640   2702  PF00047 ig
feature 2772 3026 4 square solid PFAM-A
  FT   PFAM-A     2737   2991  PF00069 pkinase
feature 159 279 5 square solid PFAM-A
  FT   PFAM-A      159    279  PF00435 spectrin
feature 281 387 5 square solid PFAM-A
  FT   PFAM-A      281    387  PF00435 spectrin
feature 507 613 5 square solid PFAM-A
  FT   PFAM-A      507    613  PF00435 spectrin
feature 614 725 5 square solid PFAM-A
  FT   PFAM-A      614    725  PF00435 spectrin
feature 848 953 5 square solid PFAM-A
  FT   PFAM-A      848    953  PF00435 spectrin
feature 1079 1185 5 square solid PFAM-A
  FT   PFAM-A     1079   1185  PF00435 spectrin
feature 1 88 0 square solid PFAM-B
  FT   PFAM-B        1     88  PB011103 Pfam-B_11103
feature 1548 1594 0 square solid PFAM-B
  FT   PFAM-B     1548   1594  PB011555 Pfam-B_11555
feature 398 483 0 square solid PFAM-B
  FT   PFAM-B      398    483  PB014085 Pfam-B_14085
feature 1672 1865 0 square solid PFAM-B
  FT   PFAM-B     1672   1865  PB018410 Pfam-B_18410
feature 2415 2568 0 square solid PFAM-B
  FT   PFAM-B     2415   2568  PB024538 Pfam-B_24538
feature 2569 2638 0 square solid PFAM-B
  FT   PFAM-B     2569   2637  PB043478 Pfam-B_43478
feature 3027 3069 0 square solid PFAM-B
  FT   PFAM-B     2992   3034  PB047479 Pfam-B_47479
feature 89 158 0 square solid PFAM-B
  FT   PFAM-B       89    158  PB005177 Pfam-B_5177
feature 965 1047 0 square solid PFAM-B
  FT   PFAM-B      965   1047  PB008452 Pfam-B_8452
feature 2638 2727 3 square solid SITE
  FT   SITE       2637   2700  DISULFID_Potential
feature 2778 2786 4 square solid SITE
  FT   SITE       2743   2751  NP_BIND_ATP By similarity
feature 2801 2801 12 square solid SITE
  FT   SITE       2766   2766  BINDING_ATP By similarity
feature 2891 2891 0 square solid SITE
  FT   SITE       2856   2856  ACT_SITE_By similarity
feature 252 359 1 square solid REPEAT
  FT   REPEAT      252    359  Spectrin 1.
feature 479 585 1 square solid REPEAT
  FT   REPEAT      479    585  Spectrin 2.
feature 819 925 1 square solid REPEAT
  FT   REPEAT      819    925  Spectrin 3.
feature 1050 1157 1 square solid REPEAT
  FT   REPEAT     1050   1157  Spectrin 4.
feature 2242 2308 1 square solid VARSPLIC
  FT   VARSPLIC   2242   2308  GSGGGGGSGGGGAPSGGSGHSGGPSSCGGAPSTSRSRPSRI
feature 2309 3073 1 square solid VARSPLIC
  FT   VARSPLIC   2309   3038  Missing (in isoform 2).
sequence
  MKAMDVLPILKEKVAYLSGGRDKRGGPILTFPARSNHDRIRQEDLRRLISYLACIPSEEV
  CKRGFTVIVDMRGSKWDSIKPLLKILQESFPCCIHVALIIKPDNFWQKQRTNFGSSKFEF
  ETNMVSLEGLTKVVDPSQLTPEFDGCLEYNHEEWIEIRVAFEDYISNATHMLSRLEELQD
  ILAKKELPQDLEGARNMIEEHSQLKKKVIKAPIEDLDLEGQKLLQRIQSSESFPKKNSGS
  GNADLQNLLPKVSTMLDRLHSTRQHLHQMWHVRKLKLDQCFQLRLFEQDAEKMFDWITHN
  KGLFLNSYTEIGTSHPHAMELQTQHNHFAMNCMNVYVNINRIMSVANRLVESGHYASQQI
  RQIASQLEQEWKAFAAALDERSTLLDMSSIFHQKAEKYMSNVDSWCKACGEVDLPSELQD
  LEDAIHHHQGIYEHITLAYSEVSQDGKSLLDKLQRPLTPGSSDSLTASANYSKAVHHVLD
  VIHEVLHHQRHVRTIWQHRKVRLHQRLQLCVFQQEVQQVLDWIENHGEAFLSKHTGVGKS
  LHRARALQKRHEDFEEVAQNTYTNADKLLEAAEQLAQTGECDPEEIYQAAHQLEDRIQDF
  VRRVEQRKILLDMSVSFHTHVKELWTWLEELQKELLDDVYAESVEAVQDLIKRFGQQQQT
  TLQVTVNVIKEGEDLIQQLRDSAISSNKTPHNSSINHIETVLQQLDEAQSQMEELFQERK
  IKLELFLHVRIFERDAIDIISDLESWNDELSQQMNDFDTEDLTIAEQRLQHHADKALTMN
  NLTFDVIHQGQDLLQYVNEVQASGVELLCDRDVDMATRVQDLLEFLHEKQQELDLAAEQH
  RKHLEQCVQLRHLQAEVKQVLGWIRNGESMLNAGLITASSLQEAEQLQREHEQFQHAIEK
  THQSALQVQQKAEAMLQANHYDMDMIRDCAEKVASHWQQLMLKMEDRLKLVNASVAFYKT
  SEQVCSVLESLEQEYKREEDWCGGADKLGPNSETDHVTPMISKHLEQKEAFLKACTLARR
  NADVFLKYLHRNSVNMPGMVTHIKAPEQQVKNILNELFQRENRVLHYWTMRKRRLDQCQQ
  YVVFERSAKQALEWIHDNGEFYLSTHTSTGSSIQHTQELLKEHEEFQITAKQTKERVKLL
  IQLADGFCEKGHAHAAEIKKCVTAVDKRYRDFSLRMEKYRTSLEKALGISSDSNKSSKSL
  QLDIIPASIPGSEVKLRDAAHELNEEKRKSARRKEFIMAELIQTEKAYVRDLRECMDTYL
  WEMTSGVEEIPPGIVNKELIIFGNMQEIYEFHNNIFLKELEKYEQLPEDVGHCFVTWADK
  FQMYVTYCKNKPDSTQLILEHAGSYFDEIQQRHGLANSISSYLIKPVQRITKYQLLLKEL
  LTCCEEGKGEIKDGLEVMLSVPKRANDAMHLSMLEGFDENIESQGELILQESFQVWDPKT
  LIRKGRERHLFLFEMSLVFSKEVKDSSGRSKYLYKSKLFTSELGVTEHVEGDPCKFALWV
  GRTPTSDNKIVLKASSIENKQDWIKHIREVIQERTIHLKGALKEPIHIPKTAPATRQKGR
  RDGEDLDSQGDGSSQPDTISIASRTSQNTLDSDKLSGGCELTVVIHDFTACNSNELTIRR
  GQTVEVLERPHDKPDWCLVRTTDRSPAAEGLVPCGSLCIAHSRSSMEMEGIFNHKDSLSV
  SSNDASPPASVASLQPHMIGAQSSPGPKRPGNTLRKWLTSPVRRLSSGKADGHVKKLAHK
  HKKSREVRKSADAGSQKDSDDSAATPQDETVEERGRNEGLSSGTLSKSSSSGMQSCGEEE
  GEEGADAVPLPPPMAIQQHSLLQPDSQDDKASSRLLVRPTSSETPSAAELVSAIEELVKS
  KMALEDRPSSLLVDQGDSSSPSFNPSDNSLLSSSSPIDEMEERKSSSLKRRHYVLQELVE
  TERDYVRDLGYVVEGYMALMKEDGVPDDMKGKDKIVFGNIHQIYDWHRDFFLGELEKCLE
  DPEKLGSLFVKHERRLHMYIAYCQNKPKSEHIVSEYIDTFFEDLKQRLGHRLQLTDLLIK
  PVQRIMKYQLLLKDFLKYSKKASLDTSELERAVEVMCIVPRRCNDMMNVGRLQGFDGKIV
  AQGKLLLQDTFLVTDQDAGLLPRCRERRIFLFEQIVIFSEPLDKKKGFSMPGFLFKNSIK
  VSCLCLEENVENDPCKFALTSRTGDVVETFILHSSSPSVRQTWIHEINQILENQRNFLNA
  LTSPIEYQRNHSGGGGGGGSGGSGGGGGSGGGGAPSGGSGHSGGPSSCGGAPSTSRSRPS
  RIPQPVRHHPPVLVSSAASSQAEADKMSGTSTPGPSLPPPGAAPEAGPSAPSRRPPGADA
  EGSEREAEPIPKMKVLESPRKGAANASGSSPDAPAKDARASLGTLPLGKPRAGAASPLNS
  PLSSAVPSLGKEPFPPSSPLQKGGSFWSSIPASPASRPGSFTFPGDSDSLQRQTPRHAAP
  GKDTDRMSTCSSASEQSVQSTQSNGSESSSSSNISTMLVTHDYTAVKEDEINVYQGEVVQ
  ILASNQQNMFLVFRAATDQCPAAEGWIPGFVLGHTSAVIVENPDGTLKKSTSWHTALRLR
  KKSEKKDKDGKREGKLENGYRKSREGLSNKVSVKLLNPNYIYDVPPEFVIPL.SEVTCET
  GETVVLRCRVCGR....PKASITWKGP....EHNTLNN..............DGHYSISY
  SDL....GEATLKIVGVTTEDDGIYTCIAVNDMG........SASSSASLRVLGPGMDGI
  MVTWKDNFDSFYSEVAELGRGRFSVVKKCDQKGTKRAVATKFVNKKLMKRDQVTHELGIL
  QSLQHPLLVGLLDTFETPTSYILVLEMADQGRLLDCVVRWGSLTEGKIRAHLGEVLEAVR
  YLHNCRIAHLDLKPENILVDESLAKPTIKLADFGDAVQLNTTYYIHQLLGNPEFAAPEII
  LGNPVSLTSDTWSVGVLTYVLLSGVSPFLDDSVEETCLNICRLDFSFPDDYFKGVSQKAK
  EFVCFLLQEDPAKRPSAALALQEQWLQAGNGRSTGVLDTSRLTSFIERRKHQNDVRPIRS
  IKNFLQSRLLPRV...............................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name APG1_HUMAN
descrip Aortic preferentially expressed protein 1 (APEG-1).
creator Homo sapiens (Human).Eukaryota;
type    PROTEIN
group 1
feature 2627 2751 5 square solid DOMAIN
  FT   DOMAIN       20    109  Ig-like.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       34     95  PF00047 ig
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ...........................MKPSPSQNRRSSDTGSKAPPTFKVSLMDQSVRE
  GQDVIMSIRVQGE....PKPVVSWLRN....RQPVRPD..............QRRFAEEA
  EG.....GLCRLRILAAERGDAGFYTCKAVNEYG........ARQCEARLEVRGE.....
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name ROR2_HUMAN
descrip Tyrosine-protein kinase transmembrane receptor ROR2 precurso
creator Homo sapiens (Human).Eukaryota;
type    PROTEIN
group 1
feature 2598 3001 5 square solid DOMAIN
  FT   DOMAIN       34    403  Extracellular (Potential).
feature 3023 3541 5 square solid DOMAIN
  FT   DOMAIN      425    943  Cytoplasmic (Potential).
feature 2619 2743 5 square solid DOMAIN
  FT   DOMAIN       55    145  Ig-like C2-type.
feature 2767 2901 5 square solid DOMAIN
  FT   DOMAIN      169    303  FZ.
feature 2914 2992 5 square solid DOMAIN
  FT   DOMAIN      316    394  Kringle.
feature 3071 3344 5 square solid DOMAIN
  FT   DOMAIN      473    746  Protein kinase.
feature 3351 3380 5 square solid DOMAIN
  FT   DOMAIN      753    782  Ser/Thr-rich.
feature 3382 3455 5 square solid DOMAIN
  FT   DOMAIN      784    857  Pro-rich.
feature 3457 3480 5 square solid DOMAIN
  FT   DOMAIN      859    882  Ser/Thr-rich.
feature 2762 2899 6 square solid PFAM-A
  FT   PFAM-A      164    301  PF01392 Fz
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       76    137  PF00047 ig
feature 2914 2992 7 square solid PFAM-A
  FT   PFAM-A      316    394  PF00051 kringle
feature 3071 3348 4 square solid PFAM-A
  FT   PFAM-A      473    750  PF00069 pkinase
feature 2993 3069 0 square solid PFAM-B
  FT   PFAM-B      395    471  PB022232 Pfam-B_22232
feature 3349 3480 0 square solid PFAM-B
  FT   PFAM-B      751    882  PB025418 Pfam-B_25418
feature 3481 3541 0 square solid PFAM-B
  FT   PFAM-B      883    943  PB089900 Pfam-B_89900
feature 2563 2640 0 square solid PFAM-B
  FT   PFAM-B        1     75  PB091325 Pfam-B_91325
feature 3077 3085 4 square solid SITE
  FT   SITE        479    487  NP_BIND_ATP By similarity
feature 3105 3105 12 square solid SITE
  FT   SITE        507    507  BINDING_ATP By similarity
feature 3213 3213 0 square solid SITE
  FT   SITE        615    615  ACT_SITE_Proton acceptor By similarity
feature 2648 2727 3 square solid SITE
  FT   SITE         83    135  DISULFID_By similarity
feature 2635 2635 5 square solid SITE
  FT   SITE         70     70  CARBOHYD_Nlinked GlcNAc Potential
feature 2786 2786 5 square solid SITE
  FT   SITE        188    188  CARBOHYD_Nlinked GlcNAc Potential
feature 2916 2916 5 square solid SITE
  FT   SITE        318    318  CARBOHYD_Nlinked GlcNAc Potential
feature 3002 3022 0 square solid TRANSMEM
  FT   TRANSMEM    404    424  Potential.
feature 2563 2597 4 square solid SIGNAL
  FT   SIGNAL        1     33  Potential.
feature 3067 3067 0 square solid MOD_RES
  FT   MOD_RES     469    469  Sulfoserine partial
feature 3069 3069 0 square solid MOD_RES
  FT   MOD_RES     471    471  Sulfoserine partial
feature 3244 3244 0 square solid MOD_RES
  FT   MOD_RES     646    646  Phosphotyrosine by autocatalysis By
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ..........................................MARGSALPRRPLLCIPAV
  W..AAAALLLSVSRTSGEVEVLDPNDPLGPLDGQDGPIPTLKGYFLNFLEPV.NNITIVQ
  GQTAILHCKVAGN....PPPNVRWLKN....DAPVVQE..............PRRIIIRK
  TE.....YGSRLRIQDLDTTDTGYYQCVATNGMKT......ITATGVLFVRLGPTHSPNH
  NFQDDYHEDGFCQPYRGIACARFIGNRTIYVDSLQMQGEIENRITAAFTMIGTSTHLSDQ
  CSQFAIPSFCHFVFPLCDARSRAPKPRELCRDECEVLESDLCRQEYTIARSNPLILMRLQ
  LPKCEALPMPESPDAANCMRIGIPAERLGRYHQCYNGSGMDYRGTASTTKSGHQCQPWAL
  QHPHSHHLSSTDFPELGGGHAYCRNPGGQMEGPWCFTQNKNVRMELCDVPSCSPRDSSKM
  GILYILVPSIAIPLVIACLFFLVCMCRNKQKASASTPQRRQLMASPSQDMEMPLINQHKQ
  AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR
  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT
  VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA
  ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV
  EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNLSNYNSSAQTS
  GASNTTQTSSLSTSPVSNVSNARYVGPKQKAPPFPQPQFIPMKGQIRPMVPPPQLYVPVN
  GYQPVPAYGAYLPNFYPVQIPMQMAPQQVPPQMVPKPSSHHSGSGSTSTGYVTTAPSNTS
  MADRAALLSEGADDTQNAPEDGAQSTVQEAEEEEEGSVPETELLGDCDTLQVDEAQVQLE
  A
}
{
name 2ncm_
descrip 
creator 
type    PROTEIN
group 1
feature 2625 2629 0 square solid STRUCT
  FT   STRUCT        4      8  STRAND
feature 2635 2639 0 square solid STRUCT
  FT   STRUCT       11     15  STRAND
feature 2644 2651 0 square solid STRUCT
  FT   STRUCT       20     27  STRAND
feature 2661 2666 0 square solid STRUCT
  FT   STRUCT       34     39  STRAND
feature 2673 2674 0 square solid STRUCT
  FT   STRUCT       43     44  STRAND
feature 2696 2700 0 square solid STRUCT
  FT   STRUCT       52     56  STRAND
feature 2710 2714 0 square solid STRUCT
  FT   STRUCT       62     66  STRAND
feature 2723 2730 0 square solid STRUCT
  FT   STRUCT       75     82  STRAND
feature 2743 2753 0 square solid STRUCT
  FT   STRUCT       88     98  STRAND
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .........................................RVLQVDIVP...SQGEISV
  GESKFFLCQVAGDA...KDKDISWFSP...NGEKLSPN..............QQRISVVW
  NDD....DSSTLTIYNANIDDAGIYKCVVTAEDGT.......QSEATVNVKIFQ......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name HV3I_HUMAN
descrip Ig heavy chain V-III region NIE.
creator Homo sapiens (Human).Eukaryota;
type    PROTEIN
group 1
feature 2625 2747 5 square solid DOMAIN
  FT   DOMAIN        1    112  Ig-like.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       15     98  PF00047 ig
feature 2648 2727 3 square solid SITE
  FT   SITE         22     96  DISULFID_Pyrrolidone carboxylic acid
feature 2625 2625 0 square solid MOD_RES
  FT   MOD_RES       1      1  Pyrrolidone carboxylic acid
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................QVQLVQSG..GGVVQP
  GRSLRLSCAASGFTF..SRYTIHWVRQAPGKGLEWVAVMSYBGBBKHYADSVNGRFTISR
  NDSK...NTLYLNMNSLRPEDTAVYYCARIRDTAM....FFAHWGQGTLVTVSS......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name HV3A_HUMAN
descrip Ig heavy chain V-III region TRO.
creator Homo sapiens (Human).Eukaryota;
type    PROTEIN
group 1
feature 2625 2740 5 square solid DOMAIN
  FT   DOMAIN        1    108  Ig-like.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       15     98  PF00047 ig
feature 2625 2625 0 square solid MOD_RES
  FT   MOD_RES       1      1  Pyrrolidone carboxylic acid
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................QVQLVQSG..GGLVKP
  GGSLRLSCVASGFSF..RDFYMSWIRZTPGKGLZWVSYIGGSGSTLYYADSVKGRFTISR
  DNAQ...KSLYLZMBSLRTZBTAVYYCAATBBFBWS.TFSLBYWGZGBLVTVSS......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name VPR1_MOUSE
descrip Immunoglobulin iota chain precursor (VPreB1 protein).
creator Mus musculus (Mouse).Eukaryota;
type    PROTEIN
group 1
feature 2625 2648 5 square solid DOMAIN
  FT   DOMAIN       20     41  Framework-1.
feature 2649 2664 5 square solid DOMAIN
  FT   DOMAIN       42     56  Complementarity-determining-1.
feature 2665 2678 5 square solid DOMAIN
  FT   DOMAIN       57     70  Framework-2.
feature 2679 2689 5 square solid DOMAIN
  FT   DOMAIN       71     81  Complementarity-determining-2.
feature 2690 2727 5 square solid DOMAIN
  FT   DOMAIN       82    115  Framework-3.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       34    117  PF00047 ig
feature 2730 2754 0 square solid PFAM-B
  FT   PFAM-B      118    142  PB063895 Pfam-B_63895
feature 2648 2727 3 square solid SITE
  FT   SITE         41    115  DISULFID_By similarity
feature 2606 2624 4 square solid SIGNAL
  FT   SIGNAL        1     19  Potential.
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .........................MAWTSVLLMLLAYLTGCGPQPMVHQPP..LASSSL
  GATIRLSCTLSNDHNI.GIYSIYWYQQRPGHPPRFLLRYFSHSDKHQGPD.IPPRFSGSK
  DTTR...NLGYLSISELQPEDEAVYYCAVGLRSQEKKRMEREWEGEKSYTDLGS......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name VPRE_HUMAN
descrip Immunoglobulin iota chain precursor (V(pre)B protein) (VpreB
creator Homo sapiens (Human).Eukaryota;
type    PROTEIN
group 1
feature 2625 2648 5 square solid DOMAIN
  FT   DOMAIN       20     41  Framework-1.
feature 2649 2664 5 square solid DOMAIN
  FT   DOMAIN       42     56  Complementarity-determining-1.
feature 2665 2678 5 square solid DOMAIN
  FT   DOMAIN       57     70  Framework-2.
feature 2679 2689 5 square solid DOMAIN
  FT   DOMAIN       71     81  Complementarity-determining-2.
feature 2690 2727 5 square solid DOMAIN
  FT   DOMAIN       82    115  Framework-3.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       34    117  PF00047 ig
feature 2648 2727 3 square solid SITE
  FT   SITE         41    115  DISULFID_By similarity
feature 2606 2624 4 square solid SIGNAL
  FT   SIGNAL        1     19  Potential.
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .........................MSWAPVLLMLFVYCTGCGPQPVLHQPP..AMSSAL
  GTTIRLTCTLRNDHDI.GVYSVYWYQQRPGHPPRFLLRYFSQSDKSQGPQ.VPPRFSGSK
  DVAR...NRGYLSISELQPEDEAMYYCAMGARSSEKEEREREWEEEMEPTAARTRVP...
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name 1d9k_A
descrip 
creator 
type    PROTEIN
group 1
feature 2628 2629 0 square solid STRUCT
  FT   STRUCT        2      3  STRAND
feature 2636 2639 0 square solid STRUCT
  FT   STRUCT        9     12  STRAND
feature 2644 2650 0 square solid STRUCT
  FT   STRUCT       17     23  STRAND
feature 2664 2666 0 square solid STRUCT
  FT   STRUCT       33     35  STRAND
feature 2674 2675 0 square solid STRUCT
  FT   STRUCT       43     44  STRAND
feature 2685 2693 0 square solid STRUCT
  FT   STRUCT       54     57  STRAND
feature 2696 2701 0 square solid STRUCT
  FT   STRUCT       60     65  STRAND
feature 2709 2714 0 square solid STRUCT
  FT   STRUCT       70     75  STRAND
feature 2726 2729 0 square solid STRUCT
  FT   STRUCT       87     90  STRAND
feature 2743 2744 0 square solid STRUCT
  FT   STRUCT       98     99  STRAND
feature 2750 2753 0 square solid STRUCT
  FT   STRUCT      105    108  STRAND
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ..............................................QVRQSP.QSLTVWE
  GETTILNCSYEDSTF....DYFPWYRQFPGKSPALLIAISLVSNKKE.....DGRFTIFF
  NKRE...KKLSLHITDSQPGDSATYFCAATGSFNK......LTFGAGTRLAVSPY.....
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name TVA2_MOUSE
descrip T-cell receptor alpha chain V region 2B4 precursor.
creator Mus musculus (Mouse).Eukaryota;
type    PROTEIN
group 1
feature 2625 2731 5 square solid DOMAIN
  FT   DOMAIN       21    113  V segment.
feature 2732 2735 5 square solid DOMAIN
  FT   DOMAIN      114    117  D segment.
feature 2736 2753 5 square solid DOMAIN
  FT   DOMAIN      118    132  J segment.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       36    111  PF00047 ig
feature 2647 2647 5 square solid SITE
  FT   SITE         42     42  CARBOHYD_Nlinked GlcNAc
feature 2605 2624 4 square solid SIGNAL
  FT   SIGNAL        1     20  domain; Receptor; Signal; T-cell.
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ........................MKSLSVSLVVLWLLLNWVNSQQNVQQSP.ESLIVPE
  GARTSLNCTFSDSAS....QYFWWYRQHSGKAPKALMSIFSNGEKE......EGRFTIHL
  NKAS...LHFSLHIRDSQPSDSALYLCAVTLYGGSG...NKLIFGTGTLLSVK.......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name TVA2_HUMAN
descrip T-cell receptor alpha chain V region CTL-L17 precursor.
creator Homo sapiens (Human).Eukaryota;
type    PROTEIN
group 1
feature 2625 2731 5 square solid DOMAIN
  FT   DOMAIN       28    120  V segment.
feature 2732 2740 5 square solid DOMAIN
  FT   DOMAIN      121    125  D segment.
feature 2741 2754 5 square solid DOMAIN
  FT   DOMAIN      126    139  J segment.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       42    118  PF00047 ig
feature 2701 2701 5 square solid SITE
  FT   SITE         93     93  CARBOHYD_Nlinked GlcNAc
feature 2648 2727 3 square solid SITE
  FT   SITE         49    116  DISULFID_Nlinked GlcNAc
feature 2598 2624 4 square solid SIGNAL
  FT   SIGNAL        1     27  domain; Receptor; Signal; T-cell.
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .................MAMLLGASVLILWLQPDWVNSQQKNDDQQVKQNSP..SLSVQE
  GRISILNCDYTNSMF....DYFLWYKKYPAEGPTFLISISSIKDKNE.....DGRFTVFL
  NKSA...KHLSLHIVPSQPGDSAVYFCAAKGAGTA....SKLTFGTGTRLQVTL......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name TVA3_MOUSE
descrip T-cell receptor alpha chain V region CTL-F3 precursor.
creator Mus musculus (Mouse).Eukaryota;
type    PROTEIN
group 1
feature 2626 2730 5 square solid DOMAIN
  FT   DOMAIN       23    114  V segment.
feature 2731 2754 5 square solid DOMAIN
  FT   DOMAIN      115    132  J segment.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       37    113  PF00047 ig
feature 2647 2647 5 square solid SITE
  FT   SITE         43     43  CARBOHYD_Nlinked GlcNAc Potential
feature 2648 2727 3 square solid SITE
  FT   SITE         44    111  DISULFID_Potential
feature 2603 2625 4 square solid SIGNAL
  FT   SIGNAL        1     22  mmunoglobulin domain; Receptor; Signal;
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ......................MNMRPDTCSVLVLLLMLRR.NNGDSVTQTE.GLVTLTE
  GLPVMLNCTYQSTYS....PFLFWYVQHLNEAPKLLFKSFTDNKRPE.....HQGFHATL
  HKSS...SSFHLQKSSAQLSDSALYYCALSNAGA......KLTFGGGTRLTVRP......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name TVA1_RABIT
descrip T-cell receptor alpha chain V region RL-5 precursor.
creator Oryctolagus cuniculus (Rabbit).Eukaryota;
type    PROTEIN
group 1
feature 2624 2730 5 square solid DOMAIN
  FT   DOMAIN       21    114  V segment.
feature 2731 2755 5 square solid DOMAIN
  FT   DOMAIN      115    134  J segment.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       37    113  PF00047 ig
feature 2755 2755 5 square solid SITE
  FT   SITE        134    134  CARBOHYD_Nlinked GlcNAc Potential
feature 2603 2623 4 square solid SIGNAL
  FT   SIGNAL        1     20  domain; Receptor; Signal; T-cell.
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ......................MFSASCSVTVVVLLITVRR.TNGASVTQTE.GPVILSE
  GSSLTLNCNYQTSYS....GFLFWYVQYLHEGPQLLLQSTTENQRME.....HQGFHATF
  VKKD...SSFHLHKSSLQLSDSAVYYCALRRGAS.....NKLTLGTGTLLKVELN.....
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name TVA1_MOUSE
descrip T-cell receptor alpha chain V region PHDS58 precursor.
creator Mus musculus (Mouse).Eukaryota;
type    PROTEIN
group 1
feature 2626 2731 5 square solid DOMAIN
  FT   DOMAIN       21    114  V segment.
feature 2732 2753 5 square solid DOMAIN
  FT   DOMAIN      115    130  J segment.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       35    112  PF00047 ig
feature 2704 2704 5 square solid SITE
  FT   SITE         90     90  CARBOHYD_Nlinked GlcNAc
feature 2605 2625 4 square solid SIGNAL
  FT   SIGNAL        1     20  mmunoglobulin domain; Receptor; Signal;
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ........................MLLALLPVLGIHFVLRD.AQAQSVTQPD.ARVTVSE
  GASLQLRCKYSYSAT....PYLFWYVQYPRQGLQLLLKYYSGDPVVQG....VNGFEAEF
  SKSN...SSFHLRKASVHWSDSAVYFCAVSGFAS......ALTFGSGTKVIVL.......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name TVA3_HUMAN
descrip T-cell receptor alpha chain V region PY14 precursor.
creator Homo sapiens (Human).Eukaryota;
type    PROTEIN
group 1
feature 2626 2729 5 square solid DOMAIN
  FT   DOMAIN       21    112  V segment.
feature 2730 2735 5 square solid DOMAIN
  FT   DOMAIN      113    118  D segment.
feature 2736 2753 5 square solid DOMAIN
  FT   DOMAIN      119    135  J segment.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       35    112  PF00047 ig
feature 2605 2625 4 square solid SIGNAL
  FT   SIGNAL        1     20  or; Signal; T-cell.
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ........................MLLLLVPVLEVIFTLGG.TRAQSVTQLG.SHVSVSE
  GALVLLRCNYSSSVP....PYLFWYVQYPNQGLQLLLKYTSAATLVKG....INGFEAEF
  KKSE...TSFHLTKPSAHMSDAAEYFCAVSDLEPNS.SASKIIFGSGTRLSIR.......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name TVA1_HUMAN
descrip T-cell receptor alpha chain V region HPB-MLT precursor (Frag
creator Homo sapiens (Human).Eukaryota;
type    PROTEIN
group 1
feature 2626 2731 5 square solid DOMAIN
  FT   DOMAIN       21    115  V segment.
feature 2732 2753 5 square solid DOMAIN
  FT   DOMAIN      116    131  J segment.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       35    113  PF00047 ig
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ........................IFASLLRAVIASICVVS.SMAQKVTQAQ.TEISVVE
  KEDVTLDCVYETRDT....TYYLFWYKQPPSGELVFLIRRNSFDEQNEIS...GRYSWNF
  QKST...SSFNFTITASQVVDSAVYFCALDSSAS......KIIFGSGTRLSIR.......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name TVB5_MOUSE
descrip T-cell receptor beta chain V region C5 precursor (Fragment).
creator Mus musculus (Mouse).Eukaryota;
type    PROTEIN
group 1
feature 2624 2731 5 square solid DOMAIN
  FT   DOMAIN        8    103  V segment.
feature 2732 2736 5 square solid DOMAIN
  FT   DOMAIN      104    108  D segment.
feature 2740 2753 5 square solid DOMAIN
  FT   DOMAIN      109    122  J segment.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       24    101  PF00047 ig
feature 2648 2727 3 square solid SITE
  FT   SITE         31     99  DISULFID_By similarity
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ....................................ILLCAKHMEAAVTQSP.RSKVAVT
  GGKVTLSCHQTNNH.....DYMYWYRQDTGHGLRLIHYSYVADSTE......KGDIPDGY
  KASRPSQENFSLILELASLSQTAVYFCASSGTGGAL...DTQYFGPGTRLLVL.......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name TVB2_MOUSE
descrip T-cell receptor beta chain V region 86T1 precursor.
creator Mus musculus (Mouse).Eukaryota;
type    PROTEIN
group 1
feature 2627 2731 5 square solid DOMAIN
  FT   DOMAIN       22    113  V segment.
feature 2732 2753 5 square solid DOMAIN
  FT   DOMAIN      114    133  J segment.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       34    111  PF00047 ig
feature 2643 2643 5 square solid SITE
  FT   SITE         36     36  CARBOHYD_Nlinked GlcNAc
feature 2693 2693 5 square solid SITE
  FT   SITE         75     75  CARBOHYD_Nlinked GlcNAc
feature 2648 2727 3 square solid SITE
  FT   SITE         41    109  DISULFID_By similarity
feature 2606 2626 4 square solid SIGNAL
  FT   SIGNAL        1     21  domain; Receptor; Signal; T-cell.
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .........................MSCRLLLYVSLCLVETALMNTKITQSP..RYLILG
  RANKSLECEQHLGH.....NAMYWYKQSAEKPPELMFLYNLKQLIR......NETVPSRF
  IPECPDSSKLLLHISAVDPEDSAVYFCASSHGQGVS.G.NTLYFGEGSRLIVV.......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name 1a7n_L
descrip 
creator 
type    PROTEIN
group 1
feature 2628 2631 0 square solid STRUCT
  FT   STRUCT        4      7  STRAND
feature 2635 2638 0 square solid STRUCT
  FT   STRUCT       10     13  STRAND
feature 2644 2650 0 square solid STRUCT
  FT   STRUCT       19     25  STRAND
feature 2662 2667 0 square solid STRUCT
  FT   STRUCT       33     38  STRAND
feature 2674 2678 0 square solid STRUCT
  FT   STRUCT       45     49  STRAND
feature 2682 2683 0 square solid STRUCT
  FT   STRUCT       53     54  STRAND
feature 2696 2701 0 square solid STRUCT
  FT   STRUCT       62     67  STRAND
feature 2709 2714 0 square solid STRUCT
  FT   STRUCT       70     75  STRAND
feature 2719 2721 3 square solid STRUCT
  FT   STRUCT       80     82  HELIX
feature 2723 2729 0 square solid STRUCT
  FT   STRUCT       84     90  STRAND
feature 2748 2752 0 square solid STRUCT
  FT   STRUCT      102    106  STRAND
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................DIVLTQSP.ASLSASV
  GETVTITCRASGNIH....NYLAWYQQKQGKSPQLLVYYTTTLADGV.....PSRFSGSG
  SG.....TQYSLKINSLQPDDFGSYYCQHFWSTP.......RTFGGGTKLEIK.......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name KV5A_MOUSE
descrip Ig kappa chain V-V region MPC11 precursor.
creator Mus musculus (Mouse).Eukaryota;
type    PROTEIN
group 1
feature 2625 2648 5 square solid DOMAIN
  FT   DOMAIN       42     64  Framework-1.
feature 2649 2663 5 square solid DOMAIN
  FT   DOMAIN       65     75  Complementarity-determining-1.
feature 2664 2678 5 square solid DOMAIN
  FT   DOMAIN       76     90  Framework-2.
feature 2679 2685 5 square solid DOMAIN
  FT   DOMAIN       91     97  Complementarity-determining-2.
feature 2686 2727 5 square solid DOMAIN
  FT   DOMAIN       98    129  Framework-3.
feature 2728 2743 5 square solid DOMAIN
  FT   DOMAIN      130    138  Complementarity-determining-3.
feature 2744 2753 5 square solid DOMAIN
  FT   DOMAIN      139    148  Framework-4.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       57    131  PF00047 ig
feature 2609 2618 1 square solid REPEAT
  FT   REPEAT       26     35  Framework-4.
feature 2621 2630 1 square solid REPEAT
  FT   REPEAT       38     47  Framework-4.
feature 2584 2612 4 square solid SIGNAL
  FT   SIGNAL        1     29  munoglobulin V region; Repeat; Signal.
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ...MHHTSMGIKMESQIQVFVFVFLWLSGVDGDIVMTQFAGVDGDIVMTQSH.KFMSTSV
  GDRVSITCKASQDVST....TVAWYQQKPGQSPKLLIYSASYRYTGV.....PDRFTGSG
  SG.....TDFTFTISSVQAEDLAVYYCQQHYSTP.......PTFGGGTKLEIKR......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
{
name LV4A_HUMAN
descrip Ig lambda chain V-IV region Bau.
creator Homo sapiens (Human).Eukaryota;
type    PROTEIN
group 1
feature 2627 2750 5 square solid DOMAIN
  FT   DOMAIN        1    102  Ig-like.
feature 2641 2729 3 square solid PFAM-A
  FT   PFAM-A       14     88  PF00047 ig
sequence
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ..............................................YGLTQP.PSLSVSP
  GQTASITCSGDKLGEQ....YVCWYQQKPGQSPVLVIYHDSKRPSGI.....PERFSGSN
  SG.....TTATLTISGTQAMDEADYYCQAWDSYT.......VIFGGGTKLTVLG......
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  ............................................................
  .
}
